# Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis

> **NCT01806272** · PHASE2 · UNKNOWN · sponsor: **Wei LUO** · enrollment: 160 (estimated)

## Conditions studied

- Nasopharyngeal Cancers

## Interventions

- **DRUG:** rhGM-CSF
- **DRUG:** Compound Vitamin B12

## Key facts

- **NCT ID:** NCT01806272
- **Lead sponsor:** Wei LUO
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2014-06
- **Final completion:** 2014-08
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2013-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01806272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01806272, "Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01806272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*